{
  "main": {
    "id": "67a85d7b04b868c8",
    "type": "split",
    "children": [
      {
        "id": "75624a39e2d70ce0",
        "type": "leaf",
        "state": {
          "type": "markdown",
          "state": {
            "file": "medu4/Major/Rheumatology/Chapter1 総論/1.4 ナイーブ T 細胞の分化とサイトカイン.md",
            "mode": "preview",
            "source": true
          }
        }
      }
    ],
    "direction": "vertical"
  },
  "left": {
    "id": "27fc4a69510a7a50",
    "type": "split",
    "children": [
      {
        "id": "de94081721359e59",
        "type": "tabs",
        "children": [
          {
            "id": "01d7ac658b53613d",
            "type": "leaf",
            "state": {
              "type": "file-explorer",
              "state": {}
            }
          },
          {
            "id": "a6c253b3f60ff90c",
            "type": "leaf",
            "state": {
              "type": "search",
              "state": {
                "query": "",
                "matchingCase": false,
                "explainSearch": false,
                "collapseAll": false,
                "extraContext": false,
                "sortOrder": "alphabetical"
              }
            }
          }
        ]
      }
    ],
    "direction": "horizontal",
    "width": 300,
    "collapsed": true
  },
  "right": {
    "id": "7943908d5a79e905",
    "type": "split",
    "children": [
      {
        "id": "5316394fbb3ec42c",
        "type": "tabs",
        "children": [
          {
            "id": "2507258beb2acae9",
            "type": "leaf",
            "state": {
              "type": "backlink",
              "state": {
                "file": "medu4/Major/Rheumatology/Chapter1 総論/1.4 ナイーブ T 細胞の分化とサイトカイン.md",
                "collapseAll": false,
                "extraContext": false,
                "sortOrder": "alphabetical",
                "showSearch": false,
                "searchQuery": "",
                "backlinkCollapsed": false,
                "unlinkedCollapsed": true
              }
            }
          }
        ]
      }
    ],
    "direction": "horizontal",
    "width": 300,
    "collapsed": true
  },
  "active": "75624a39e2d70ce0",
  "lastOpenFiles": [
    "medu4/Major/Rheumatology/Chapter4 全身疾患/4.2 抗リン脂質抗体症候群〈APS〉.md",
    "medu4/Major/Rheumatology/Chapter2 アレルギー/2.3 III 型アレルギー.md",
    "medu4/Major/Rheumatology/Chapter5 血管炎/5.9 リウマチ性多発筋痛症〈PMR〉.md",
    "medu4/Major/Rheumatology/Chapter3 関節疾患/3.3 線維筋痛症.md",
    "medu4/Major/Rheumatology/Chapter3 関節疾患/3.2 シェーグレン症候群〈SS〉.md",
    "medu4/Major/Rheumatology/Chapter3 関節疾患/3.1 関節リウマチ〈RA〉.md",
    "medu4/Major/Respiratory Medicine/Chapter3 アレルギー性呼吸器疾患/3.1 気管支喘息.md",
    "medu4/Major/Rheumatology/Chapter2 アレルギー/2.8 血管性浮腫〈Quincke 浮腫〉.md",
    "medu4/Major/Rheumatology/Chapter1 総論/1.6 免疫の治療.md",
    "medu4/Appendix/Infusion/1. 代表的な輸液製剤の組成とその単位.md"
  ]
}